'Virtual' house calls comparable to in-person care for people with Parkinson's disease, study finds

March 11, 2013

A small study of 20 people with Parkinson's disease suggests that "virtual house calls" using Web-based video conferencing provide clinical benefits comparable to in-person physician office visits, while saving patients and their caregivers time and travel.

"It appears we can use the same technology Grandma uses to chat with her grandson to provide her with valuable medical care in her home," says study leader Ray Dorsey, M.D., M.B.A., an associate professor of neurology at the Johns Hopkins University School of Medicine. "If this proof-of-concept study is affirmed, the findings open the door to a new era where anyone anywhere can receive the care she needs."

A report on the study, conducted by researchers at Johns Hopkins and the University of Rochester Medical Center is being published online in JAMA Neurology.

Dorsey cautions that wider use of virtual house calls is not without hurdles. For example, under current Medicare rules, physicians are not reimbursed for providing remote care directly into the home. There are also licensing issues.

Doctors may not treat patients in states in which they are not licensed, so that means a patient from, say, Delaware, could come to Johns Hopkins in Baltimore for treatment, but a Johns Hopkins physician could not conduct a virtual house call with that same patient without a Delaware medical license.

"Reimbursement and licensure issues are trailing innovation and, if anything, act as a hindrance," Dorsey says. "There's really a disconnect."

For the study, Dorsey and his colleagues at Johns Hopkins and the University of Rochester Medical Center enrolled 20 of their Parkinson's disease (PD) patients who had home Internet access. Nine were randomly selected to receive three virtual house calls, while 11 were scheduled for three in-person visits to a physician's office over the course of seven months.

Roughly the same number of patients made their scheduled visits (one in-person patient missed a visit because of a car accident on the way to the appointment), and quality-of-life changes did not differ between the two groups. The researchers also found that the care was no better—but no worse—for those seen "virtually" or in person.

They also found that, compared to in-person visits, each telemedicine visit saved participants and their caregivers on average 100 miles of travel and three hours of time.

PD is a disorder of the brain that leads to shaking (tremors), slowness of movement, stiffness and difficulty walking. PD usually develops after age 50 and is one of the most common nervous system disorders of the elderly, affecting an estimated 500,000 Americans. That number is expected to nearly double over the next generation, Dorsey notes.

Research has shown that 42 percent of Medicare beneficiaries with PD did not receive care from a neurologist in the first four years after diagnosis, and that patients who don't see a neurologist are 20 percent more likely to die in the first six years after diagnosis. In addition, Dorsey notes, such patients are 14 percent more likely to fracture a hip and 21 percent more likely to be placed in a nursing home in the first year after diagnosis. And he says money saved by preventing the need for hospitalization and skilled nursing care would more than make up for the small reimbursement costs to neurologists who conduct virtual house calls.

"Physician visits are a rounding error to Medicare in the economic scheme of things," says Dorsey, director of the Johns Hopkins and Movement Disorders Center.

Dorsey says that virtual may be especially important for people who live far from large medical centers where specialists are more likely to practice.

Over the Web, neurologists can perform nearly all of the tests that would be done in a regular office visit for a Parkinson's patient, he says. The physician can watch the patient walk, observe tremors, check the rate at which the patient blinks and assess facial expressions—all measures of the slowing of movement. The principal test that cannot be done is one that assesses stiffness in the arms.

Only larger studies can affirm the comparability and effectiveness of telemedicine, Dorsey says, along with the value to people with other diseases.

Explore further: The doctor will see all of you now? Group doctor visits may be feasible for Parkinson's disease

Related Stories

The doctor will see all of you now? Group doctor visits may be feasible for Parkinson's disease

April 27, 2011
Group appointments where doctors see several people for a longer time may be feasible for Parkinson's disease, according to a new study published in the April 27, 2011, online issue of Neurology®, the medical journal ...

Study suggests seeing a neurologist helps people with Parkinson's live longer

August 10, 2011
People with Parkinson's disease who go to a neurologist for their care are more likely to live longer, less likely to be placed in a nursing home and less likely to break a hip than people who go to a primary care physician, ...

Guided care provides better quality of care for chronically ill older adults

January 17, 2013
Patients who received Guided Care, a comprehensive form of primary care for older adults with chronic health problems, rated the quality of their care much higher than patients in regular primary care, and used less home ...

Going to physician visits with older loved ones could improve care

January 23, 2012
Family companions who routinely accompany older adults to physician office visits could be helpful to health care quality improvement efforts, according to a new study led by researchers at the Johns Hopkins Bloomberg School ...

Recommended for you

Researchers find new path to promising Parkinson's treatment

September 19, 2017
Three researchers at The University of Alabama are part of work that is leading to a new direction for drug discovery in the quest to treat Parkinson's disease.

Tug of war between Parkinson's protein and growth factor

September 18, 2017
Alpha-synuclein, a sticky and sometimes toxic protein involved in Parkinson's disease (PD), blocks signals from an important brain growth factor, Emory researchers have discovered.

Medical history can point to earlier Parkinson's disease diagnosis

September 15, 2017
Before symptoms become pronounced, there is no reliable way to identify who is on track to develop Parkinson's disease, a debilitating movement disorder characterized by tremors, slowness of movement, stiffness, and difficulty ...

Brain rewiring in Parkinson's disease may contribute to abnormal movement

September 14, 2017
The brain's own mechanisms for dealing with the loss of dopamine neurons in Parkinson's disease may be a source of the disorder's abnormal movement, according to a Northwestern Medicine study published in Neuron.

Treating with antioxidants early in Parkinson's disease process may halt degeneration and improve neuronal function

September 7, 2017
Northwestern Medicine scientists have identified a toxic cascade that leads to neuronal degeneration in patients with Parkinson's disease (PD) and figured out how to interrupt it, reports a study to be published September ...

New diagnostic tool spots first signs of Parkinson's disease

September 6, 2017
Researchers have developed the first tool that can diagnose Parkinson's disease when there are no physical symptoms, offering hope for more effective treatment of the condition.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.